Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 31 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 10766892

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  2. US 10766903

    Piperidine derivatives as inhibitors of ubiquitin specific protease 7

    ALMAC DISCOVERY LIMITED · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  3. US 10759791

    Mammalian and bacterial nitric oxide synthase inhibitors

    Northwestern University · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  4. US 10759796

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  5. US 10759759

    Prodrugs of kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  6. US 10759816

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  7. US 10759813

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  8. US 10759793

    2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors

    Almirall, S.A. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  9. US 10759774

    Inhibitors of hepatitis B virus targeting capsid assembly

    Regents of the University of Minnesota · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  10. US 10758511

    Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  11. US 10758530

    Carboxamide derivatives useful as rsk inhibitors

    PHOENIX MOLECULAR DESIGNS · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  12. US 10752607

    Polymorphs of N-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  13. US 10751332

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  14. US 10752598

    Aryldiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  15. US 10752623

    Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

    Xenon Pharmaceuticals Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  16. US 10752639

    Bridged bicyclic inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  17. US 10751416

    IL-26 inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  18. US 10752581

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    The Regents of the University of California Santa · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  19. US 10745405

    Glucuronide prodrugs of Janus kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  20. US 10744104

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  21. US 10745420

    Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  22. US 10736894

    Methods of treating developmental syndromes with PDE10A inhibitors

    OVID THERAPEUTICS INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  23. US 10738047

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  24. US 10738043

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted